153 related articles for article (PubMed ID: 34058874)
1. Patients with an increased time to treatment initiation have a poorer overall survival after definitive surgery for localized high-grade soft-tissue sarcoma in the extremity or trunk : report from the National Cancer Database.
Ogura K; Fujiwara T; Healey JH
Bone Joint J; 2021 Jun; 103-B(6):1142-1149. PubMed ID: 34058874
[TBL] [Abstract][Full Text] [Related]
2. Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database.
Curtis GL; Lawrenz JM; George J; Styron JF; Scott J; Shah C; Shepard DR; Rubin B; Nystrom LM; Mesko NW
J Surg Oncol; 2018 Jun; 117(8):1776-1785. PubMed ID: 29949654
[TBL] [Abstract][Full Text] [Related]
3. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
Smartt AA; Jang ES; Tyler WK
Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
[TBL] [Abstract][Full Text] [Related]
4. Time to treatment initiation and survival in adult localized, high-grade soft tissue sarcoma.
Featherall J; Curtis GL; Lawrenz JM; Jin Y; George J; Scott J; Shah C; Shepard D; Rubin BP; Nystrom LM; Mesko NW
J Surg Oncol; 2019 Dec; 120(7):1241-1251. PubMed ID: 31587292
[TBL] [Abstract][Full Text] [Related]
5. Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer Database.
Lawrenz JM; Curtis GL; Styron JF; George J; Anderson PM; Zahler S; Shepard DR; Rubin BP; Nystrom LM; Mesko NW
Sarcoma; 2018; 2018():1728302. PubMed ID: 30533997
[TBL] [Abstract][Full Text] [Related]
6. Effects of time to treatment initiation on outcomes for soft tissue sarcomas.
Ryu JH; Rahman J; Deo S; Flint M
J Surg Oncol; 2023 Jun; 127(7):1174-1186. PubMed ID: 36939055
[TBL] [Abstract][Full Text] [Related]
7. The Interval Between Preoperative Radiation and Surgery Is Not Associated with Overall Survival for Soft-tissue Sarcomas: An Analysis of the National Cancer Database.
Collier CD; Kim CY; Liu RW; Getty PJ
Clin Orthop Relat Res; 2021 Mar; 479(3):506-517. PubMed ID: 32401002
[TBL] [Abstract][Full Text] [Related]
8. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
[TBL] [Abstract][Full Text] [Related]
9. Regional variation in the survival of patients with a soft-tissue sarcoma of the extremity and trunk wall under a centralized care system : what has been the impact of national policies in the UK?
Fujiwara T; Evans S; Stevenson J; Tsuda Y; Gregory J; Grimer RJ; Abudu S
Bone Joint J; 2021 Sep; 103-B(9):1541-1549. PubMed ID: 34465152
[TBL] [Abstract][Full Text] [Related]
10. Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone Sarcoma.
Lawrenz JM; Featherall J; Curtis GL; George J; Jin Y; Anderson PM; Shepard DR; Reith JD; Rubin BP; Nystrom LM; Mesko NW
Sarcoma; 2020; 2020():2984043. PubMed ID: 32454786
[TBL] [Abstract][Full Text] [Related]
11. Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan.
Sekimizu M; Ogura K; Yasunaga H; Matsui H; Tanaka S; Inagaki K; Kawai A
BMC Cancer; 2019 Jul; 19(1):657. PubMed ID: 31272407
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
Cushman TR; Jones B; Akhavan D; Rusthoven CG; Verma V; Salgia R; Sedrak M; Massarelli E; Welsh JW; Amini A
Clin Lung Cancer; 2021 Jan; 22(1):e84-e97. PubMed ID: 33039348
[TBL] [Abstract][Full Text] [Related]
13. Defining a textbook surgical outcome for patients undergoing surgical resection of intermediate and high-grade soft tissue sarcomas of the extremities.
Lazarides AL; Cerullo M; Moris D; Brigman BE; Blazer DG; Eward WC
J Surg Oncol; 2020 Oct; 122(5):884-896. PubMed ID: 32691847
[TBL] [Abstract][Full Text] [Related]
14. Survival Impact of Time to Initiation of Adjuvant Radiation for Merkel Cell Carcinoma: An Analysis of the National Cancer Database.
Yusuf M; Gaskins J; Tennant P; Bumpous J; Dunlap N
Pract Radiat Oncol; 2019; 9(4):e372-e385. PubMed ID: 30926480
[TBL] [Abstract][Full Text] [Related]
15. Predictors of time to definitive surgery and survival in Merkel cell carcinoma: analysis of the US National Cancer Database.
Desai AD; Behbahani S; Samie FH
Clin Exp Dermatol; 2022 Jul; 47(7):1275-1282. PubMed ID: 35150153
[TBL] [Abstract][Full Text] [Related]
16. Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma.
Voss RK; Chiang YJ; Torres KE; Guadagnolo BA; Mann GN; Feig BW; Cormier JN; Roland CL
Ann Surg Oncol; 2017 Oct; 24(11):3271-3278. PubMed ID: 28741122
[TBL] [Abstract][Full Text] [Related]
17. Impact of NICE guidelines on the survival of patients with soft-tissue sarcomas.
Fujiwara T; Grimer RJ; Evans S; Medellin Rincon MR; Tsuda Y; Le Nail LR; Abudu S
Bone Joint J; 2021 Mar; 103-B(3):569-577. PubMed ID: 33641420
[TBL] [Abstract][Full Text] [Related]
18. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma.
Strong EA; Park SH; Ethun CG; Chow B; King D; Bedi M; Charlson J; Mogal H; Tsai S; Christians K; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Gamblin TC; Cardona K; Clarke CN
Surgery; 2020 Oct; 168(4):760-767. PubMed ID: 32736869
[TBL] [Abstract][Full Text] [Related]
19. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
Murphy CT; Galloway TJ; Handorf EA; Egleston BL; Wang LS; Mehra R; Flieder DB; Ridge JA
J Clin Oncol; 2016 Jan; 34(2):169-78. PubMed ID: 26628469
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma.
Brewster R; Purington N; Henry S; Wood D; Ganjoo K; Bui N
JAMA Netw Open; 2021 Mar; 4(3):e210845. PubMed ID: 33666664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
